Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-25-018463
Filing Date
2025-10-17
Accepted
2025-10-17 16:16:00
Documents
15
Effectiveness Date
2025-10-17

Document Format Files

Seq Description Document Type Size
1 S-8 forms-8.htm S-8 93948
2 EX-5.1 ex5-1.htm EX-5.1 13677
3 EX-23.1 ex23-1.htm EX-23.1 3737
4 EX-FILING FEES ex107.htm   iXBRL EX-FILING FEES 32850
5 GRAPHIC ex5-1_001.jpg GRAPHIC 8764
  Complete submission text file 0001493152-25-018463.txt   279961

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 5692
Mailing Address 34 SHREWSBURY AVE SUITE 1C RED BANK NJ 07701
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Filer) CIK: 0001861657 (see all company filings)

EIN.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-290936 | Film No.: 251401033
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)